Medical News Summary: Drug company stops marketing plans for new lung cancer drug due to poor trial results

About: Drug company stops marketing plans for new lung cancer drug due to poor trial results
Date: 4 January 2005
Source: News Scotsman
Author: Lyndsay Moss
Medical News Summary (summary of medical news story as reported by News Scotsman): AstraZeneca has withdrawn its application to market the small cell lung cancer drug, Iressa in Europe. Initial trials of the drug found produced a statistically significant reduction in tumor size but further trials showed that it did not necessarily deliver any worthy survival benefits. The company has reaffirmed its belief in the safety of the cholesterol drug Crestor which has recently been under scrutiny.
URL: http://news.scotsman.com/latest.cfm?id=3959847
Related Disease Topics: Lung cancer, Cancer, Small cell lung cancer (type of Lung cancer), High cholesterol

---

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

• Medication
• medication and lung cancer
• medication and cancer
• medication and small cell lung cancer
• Research
• research and lung cancer
• research and cancer
• research and small cell lung cancer
• medication and high cholesterol
• Medication and Crestor

Medical Tools & Articles:

Next articles:

• Risk Factor Center
• Medical Statistics Center
• Medical Treatment Center
• Prevention Center
• Medical Tests Center

Medical Articles:

• Disease & Treatments Search
• Online Diagnosis
• Misdiagnosis Center
• Full list of interesting articles